ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 45

$595K Total Retail Price of All Prescriptions

Rank: 16 out of 45

290 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

29% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 25%.

Risky Drugs to Seniors

3% of this provider’s 2,917 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 369 101 S3 1 1
FUROSEMIDE 334 102 2 6
AMLODIPINE BESYLATE 305 107 3 7
PRAVASTATIN SODIUM 285 68 4 14
LISINOPRIL 249 115 5 2
ZETIA 235 67 6 50
METFORMIN HCL 234 46 7 8
LEVOTHYROXINE SODIUM 203 64 8 5
OMEPRAZOLE 200 73 9 3
METOPROLOL TARTRATE 198 106 10 10
TRAMADOL HCL 157 31 11 20
CYCLOBENZAPRINE HCL 137 27 R 12 45
HYDROCHLOROTHIAZIDE 131 47 13 11
POTASSIUM CHLORIDE 125 52 14 13
RANITIDINE HCL 120 56 15 16
DICLOFENAC SODIUM 119 16 16 80
CITALOPRAM HBR 117 23 17 21
GABAPENTIN 110 0 18 9
NEXIUM 105 38 19 19
CRESTOR 98 51 20 23
TRILIPIX 96 43 21 174
JANUVIA 94 22 22 91
SERTRALINE HCL 94 36 22 24
AMITRIPTYLINE HCL 94 12 R 22 42
METOPROLOL SUCCINATE 93 37 25 18
FENOFIBRATE 90 13 26 64
BENAZEPRIL HCL 88 31 27 75
GLIMEPIRIDE 86 29 28 72
SIMVASTATIN 85 58 29 4
ATORVASTATIN CALCIUM 83 0 30 12
WARFARIN SODIUM 80 25 31 17
MELOXICAM 79 40 32 28
ACTOS 73 32 33 115
ALENDRONATE SODIUM 73 55 33 62
FLUOXETINE HCL 68 12 35 47
LOVASTATIN 67 23 36 49
VENTOLIN HFA 66 0 37 68
IBUPROFEN 65 18 38 40
NIASPAN 62 12 39 118
PROAIR HFA 61 19 40 38
GLIPIZIDE XL 60 27 41 147
DIOVAN 58 38 42 43
LOVAZA 58 40 42 76
BUSPIRONE HCL 57 0 44 73
CLOPIDOGREL 55 13 45 26
TRAZODONE HCL 54 0 46 32
INSULIN SYRINGE 52 16 47 84
ADVAIR DISKUS 52 27 47 70
LANTUS 51 31 49 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.